OneMedNet Secures Mid Six-Figure Re-Order from Radiology Foundation Model Company

What happened

OneMedNet announced a mid six-figure re-order from a foundation model company focused on radiology models, following delivery of an initial dataset. This re-order validates the quality and completeness of the company's first-party real-world data and signals potential for repeat business in the AI/radiology space. However, the company remains in a precarious financial position, with sub-scale revenue ($643k in FY2024) and a going-concern warning, as highlighted in the latest DeepValue report. The re-order, while positive, is modest relative to the company's cash burn and does not resolve acute liquidity constraints (cash of $0.1M and Bitcoin of $1.6M as of June 30, 2025). Investors should view this as an early sign of iRWD traction but not yet a thesis-changing event.

Implication

This re-order is encouraging because it demonstrates customer satisfaction and repeatability in the iRWD segment, which is central to the company's pivot away from the legacy BEAM product. However, a single mid six-figure order is still small relative to the cash burn and does not move the needle on the going-concern risk. Investors should monitor whether this customer expands to larger or multi-year contracts and whether other foundation model companies follow, as that would indicate broader market acceptance. Until the company shows consecutive quarters with iRWD revenue above $1 million and improves gross margins, the SELL stance remains appropriate. Additionally, the Nasdaq compliance overhang and reliance on dilutive financing continue to cap upside, making the risk/reward unfavorable at current levels.

Thesis delta

No material shift to the investment thesis. The re-order is a minor positive signal of iRWD demand, but the underlying concerns of liquidity, sub-scale revenue, and Nasdaq compliance remain unchanged. The SELL stance is maintained pending sustained iRWD revenue growth and improved balance sheet.